Skip to main content
Elizabeth Franzmann, MD, Otolaryngology (ENT), Miami, FL, Miami Veterans Affairs Healthcare System

ElizabethJFranzmannMD

Otolaryngology (ENT) Miami, FL

Head & Neck Oncologic Surgery

Professor, Otolaryngology, University of Miami School of Medicine

Dr. Franzmann is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Connect with other colleagues in the same hospital or clinic
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

See Dr. Franzmann's full profile

Already have an account?

Summary

  • Dr. Elizabeth Franzmann is an otolaryngologist in Miami, FL and is affiliated with multiple hospitals in the area, including Miami Veterans Affairs Healthcare System, University of Miami Hospital, and University of Miami Hospital and Clinics. She received her medical degree from David Geffen School of Medicine at UCLA and has been in practice 22 years. She specializes in head & neck oncologic surgery and is experienced in head and neck oncology, head and neck oncology, head and neck neoplasms. Her research interests are in early detection of oral and oropharyngeal cancer.

Education & Training

  • University of Miami/Jackson Health System
    University of Miami/Jackson Health SystemResidency, Otolaryngology - Head and Neck Surgery, 2000 - 2002
  • University of Miami/Jackson Health System
    University of Miami/Jackson Health SystemInternship, Transitional Year, 1995 - 1996
  • David Geffen School of Medicine at UCLA
    David Geffen School of Medicine at UCLAClass of 1995

Certifications & Licensure

  • FL State Medical License
    FL State Medical License 1997 - 2023
  • American Board of Otolaryngology - Head and Neck Surgery Otolaryngology

Awards, Honors, & Recognition

  • Fellow (FACS) American College of Surgeons
  • Fellow (FAAO-HNS) American Academy of Otolaryngology - Head and Neck Surgery

Clinical Trials

Publications & Presentations

PubMed

Press Mentions

  • Vigilant Biosciences Announces Multiple Poster Presentations in Support of OncAlert® Oral Cancer and OncAlert Labs Product Lines
    Vigilant Biosciences Announces Multiple Poster Presentations in Support of OncAlert® Oral Cancer and OncAlert Labs Product LinesMarch 22nd, 2017
  • COVID-19 Vaccine Trials Exhibit Early Success
    COVID-19 Vaccine Trials Exhibit Early SuccessNovember 24th, 2020

Grant Support

  • Salivary Soluble Markers In Head And Neck CancerNational Cancer Institute2007–2010
  • Salivary Soluble CD44: A Molecular Marker For Head And *National Cancer Institute2005
  • Salivary Soluble CD44: A Molecular Marker For HnsccNational Cancer Institute2004

Professional Memberships

Hospital Affiliations

Industry Relationships

  • Chief Scientific Officer, Vigilant Biosciences